VOYA Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

VOYA Investment Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,559	Closed	-$843K	–	2727
2020 Q1	$843K	Buy	17,559 +364	+2%	+$16.9K	﹤0.01%	1310
2019 Q4	$807K	Sell	17,195 -361,228	-95%	-$16M	﹤0.01%	1588
2019 Q3	$8.95M	Buy	378,423 +131,226	+53%	+$3.89M	0.02%	629
2019 Q2	$7.43M	Buy	+247,197	New	+$5.66M	0.02%	684

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

VOYA Investment Management's RARX Position: Q2 2020 in Review

VOYA Investment Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 17,559 shares — an estimated $843K sold.

VOYA Investment Management first reported a position in RARX in Q2 2019 and held it in 4 quarters. The position peaked at $8.95M in Q3 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

VOYA Investment Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
VOYA Investment Management sold 17,559 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $843K.
VOYA Investment Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
VOYA Investment Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $8.95M in Q3 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on VOYA Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.